Literature DB >> 10781900

Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS.

J M Nelissen1, R Torensma, M Pluyter, G J Adema, R A Raymakers, Y van Kooyk, C G Figdor.   

Abstract

OBJECTIVE: Osteoblasts play an important role in regulating hematopoiesis in the bone marrow. Here we show that U2-OS, a widely used osteoblastic cell line derived from an osteosarcoma, has the capacity to support proliferation of human hematopoietic progenitor cells in vitro. In this study, U2-OS cells are characterized at the molecular level to unravel the molecular mechanisms underlying the support of hematopoiesis.
MATERIALS AND METHODS: U2-OS was analyzed in great detail using RT-PCR and flow cytometry. In addition, a cDNA library was constructed and randomly sequenced to obtain insight in the repertoire of expressed molecules.
RESULTS: A broad panel of growth factors and cytokines is expressed by U2-OS. TGF-beta, GM-CSF, c-kit ligand, and IL-7 are produced constitutively and IL-1beta, IL-6, IL-8, TNF-alpha, IFN-gamma, and MIP1-alpha are upregulated upon stimulation. In addition to those, mRNAs of the CC chemokine LARC and leukemia inhibitory factor were identified. U2-OS cells express high levels of beta1-integrins at the cell surface: VLA-2, VLA-3, VLA-4, VLA-5, VLA-6, and the integrin alphavbeta3. Besides integrins, ALCAM and NCAM are detected on the cell surface of U2-OS. Interestingly, we show that CD34(+) progenitor cells expressing ALCAM are highly proliferative when compared with CD34(+) ALCAM(low) cells, hinting at a role for ALCAM in anchoring progenitor cells to the bone marrow stroma. Interestingly, random sequencing of an U2-OS cDNA library yielded almost 10% of novel cDNAs with a potential role in hematopoiesis. The involvement of these novel molecules in hematopoiesis is an interesting target for future investigations.
CONCLUSIONS: We conclude that U2-OS supports outgrowth of hematopoietic progenitor cells and accordingly expresses adhesion molecules and growth factors and a number of novel, as yet uncharacterized potentially interesting genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781900     DOI: 10.1016/s0301-472x(00)00127-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

1.  Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton.

Authors:  J M Nelissen; I M Peters; B G de Grooth; Y van Kooyk; C G Figdor
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

2.  Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.

Authors:  Scott A Ely; Daniel M Knowles
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis.

Authors:  M C Honorati; S Neri; L Cattini; A Facchini
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

4.  Alcam regulates long-term hematopoietic stem cell engraftment and self-renewal.

Authors:  Robin Jeannet; Qi Cai; Hongjun Liu; Hieu Vu; Ya-Huei Kuo
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

Review 5.  Mesenchymal progenitors and the osteoblast lineage in bone marrow hematopoietic niches.

Authors:  Cristina Panaroni; Yi-Shiuan Tzeng; Hamid Saeed; Joy Y Wu
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

6.  Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.

Authors:  Cicerone Tudor; Joost te Riet; Christina Eich; Rolf Harkes; Nick Smisdom; Jessica Bouhuijzen Wenger; Marcel Ameloot; Matthew Holt; Johannes S Kanger; Carl G Figdor; Alessandra Cambi; Vinod Subramaniam
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

7.  Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor.

Authors:  Noah Federman; Jason Chan; Jon O Nagy; Elliot M Landaw; Katelyn McCabe; Anna M Wu; Timothy Triche; Hyunggyoo Kang; Bin Liu; James D Marks; Christopher T Denny
Journal:  Sarcoma       Date:  2012-09-11

8.  Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis.

Authors:  R A Hooker; B R Chitteti; P H Egan; Y H Cheng; E R Himes; T Meijome; E F Srour; R K Fuchs; M A Kacena
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-03       Impact factor: 2.041

9.  Transcriptomic profile adaptations following exposure of equine satellite cells to nutriactive phytochemical gamma-oryzanol.

Authors:  K A Szcześniak; A Ciecierska; P Ostaszewski; T Sadkowski
Journal:  Genes Nutr       Date:  2016-03-17       Impact factor: 5.523

10.  Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation.

Authors:  Fumio Arai; Osamu Ohneda; Takeshi Miyamoto; Xiu Qin Zhang; Toshio Suda
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.